Lori Anne Kunkel, Director at Loxo Oncology, Inc. (LOXO), sold 7,800 shares at $84.15 ($663K) on 2017-11-02, disclosed to the SEC on 2017-11-06.
Open-market sale of $663k LOXO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $84.15 | 1,800 | $151K | 22.8% |
| 2 | $85.21 | 2,800 | $239K | 36.0% |
| 3 | $85.21 | 2,800 | $239K | 36.0% |
| 4 | $86.28 | 400 | $35K | 5.2% |
| Total | $85.02 avg | 7,800 | $663K | 100% |
| Filing → |
| CRIS | SELL | 2019-01-25 | $16K | — | Filing → |
| LOXO | SELL | 2018-10-03 | $852K | — | Filing → |
| LOXO | SELL | 2018-06-18 | $14.1M | — | Filing → |